GL1X · GenesisL1 explorer

MolNFT v1 · #5654 · protein

Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures

1EOJ · Alpha thrombin: “Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures”. X-ray diffraction, 1 ligand (BBS), 1 pocket (best druggability 0.28). MolNFT v1 #5654 on GenesisL1: 3D structure…

PDB
1EOJ
Type
protein
Length
291 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha thrombin; Thrombin inhibitor P798
EC
3.4.21.5
UniProt
P00734
Ligands
BBS
Pockets
1 · best druggability 0.28

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha thrombin (EC 3.4.21.5)protein27817% helix, 31% strandP00734
BThrombin inhibitor P798protein130% helix, 0% strand—

Ligands and binding sites

  • BBS · 4-tert-butylbenzenesulfonic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1610.280.7314empty

Interfaces

1 interface between chains.

  • A–B · 1100 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 3 modified, 1 covalent (disulfide, nonstandard, covalent ligand).

Compared structures

  • 1EOJ · Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.